Ferric carboxymaltose: all 159 studies that test it
Page 1 of 2. Open to participants first (24), then studies with results posted, then the rest; newest registration first within each.
- Intravenous Iron in the Management of Drug-resistant Restless Legs syndromeINot yet recruitingNCT07822607Phase 2
- Ferric Carboxymaltose Versus Iron Sucrose for Iron Deficiency Anemia After Radical Gastrectomy for Gastric CancerNot yet recruitingNCT07772453Phase 4
- Comparing Two Intravenous Iron Treatments for Anemia in Kurdish Pregnant WomenNot yet recruitingNCT07721519Not applicable
- Bioequivalence Study of Ferric Carboxymaltose Injection in Healthy Chinese Participants Under Fasting ConditionsRecruitingNCT07606105Phase 1
- Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary SyndromeRecruitingNCT07476859Phase 4
- The Role of Ferric Carboxymaltose in the Treatment of Pediatric Iron Deficiency Anemia in the Emergency DepartmentNot yet recruitingNCT07414199Phase 4
- Iron Infusion in Patients Undergoing Transcatheter Aortic Valve ImplantationRecruitingNCT07370688Phase 4
- The Impact of IV Iron on Exercise Capacity and Quality of Life in Pulmonary HypertensionRecruitingNCT07359599Phase 4
- IntraVenous Iron in Kids With Iron Deficiency and Scoliosis StudyRecruitingNCT07217873Phase 2/3
- The Effectiveness of Preoperative Iron Therapy in Improving Anemia After Multi-level Lumbar Fusion in the ElderlyRecruitingNCT07057973Not applicable
- Intravenous Iron Effects on Performance at High AltitudeRecruitingNCT06686693Phase 4
- IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron DeficiencyNot yet recruitingNCT06434025Phase 3
- IV Iron-induced Hypophosphatemia After RYGBRecruitingNCT06350955Phase 4
- Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency AnemiaRecruitingNCT06061393Phase 4
- The Prevalence of Iron Deficiency and the Effectiveness of Ferinject® in Patients With HFpEF (ID-HFpEF)RecruitingNCT05793996Phase 4
- Effect of INtravenous FERRic Carboxymaltose Onmortality and Cardiovascular Morbidity, and Quality of Life in Iron Deficient Patients With Recent Myocardial infarCTionRecruitingNCT05759078Phase 4
- Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trialRecruitingNCT05744219Phase 3
- Impact of Intravenous Iron on Musculoskeletal Function in Older AdultsNot yet recruitingNCT05708170Phase 4
- Patient Blood Mangement (PBM) Using IV Iron in Patients With Gynecologic CancerNot yet recruitingNCT05669872Not applicable
- Efficacy and Safety oF FErric CarboxymalTose in Patients With Advanced Gastric Cancer(EFFECT-AGC)RecruitingNCT05226169Phase 3
- Iron Supplementation in TAVI and SAVR Patients With Iron DeficiencyNot yet recruitingNCT04786769Phase 4
- Preoperative i.v. Iron Substitution in Patients With Colon CancerRecruitingNCT04653181Not applicable
- Preoperative Intravenous Iron Therapy in Patients With Gastric CancerNot yet recruitingNCT04168346Phase 4
- Impact of Intravenous Iron Treatment of Preoperative Anemia in Patients With LEAD (IRONPAD)RecruitingNCT04083755Phase 4
- An Open Study on the Efficacy of Iron Therapy Using iv Iron Relative to Oral Iron for Increasing LV Systolic FunctionCompletedNCT05309499Not applicableResults posted
- Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients With Iron Deficiency Anemia and Unsatisfactory Response Oral Iron Under Study Protocol 1VIT17044CompletedNCT04269707Phase 3Results posted
- Use of Intravenous Ferric Carboxymaltose in Treatment of Anemia in Cancer Patients Undergoing ChemotherapyCompletedNCT04246021Not applicableResults posted
- To Assess the Impact of Ferric Carboxymaltose Compared With Iron Sucrose in Chinese Subjects on Correcting Iron Deficiency AnaemiaCompletedNCT03591406Phase 3Results posted
- Multicenter Randomized Active-controlled Study to Investigate Efficacy & Safety of IV FCM in Pediatric Patients With IDACompletedNCT03523117Phase 3Results posted
- Ferric Carboxymaltose to Improve Skeletal Muscle Metabolism in Heart Failure Patients With Functional Iron DeficiencyTerminatedNCT03218384Phase 2Results posted
- Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-StudyCompletedNCT03037931Phase 3Results posted
- Efficacy of Ferric Carboxymaltose in Gastrointestinal Stromal Tumor (GIST) Patients With Iron Deficiency Anemia (IDA) Receiving Systemic TherapyTerminatedNCT02949947Phase 2Results posted
- Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron DeficiencyCompletedNCT02937454Phase 4Results posted
- Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency AnemiaTerminatedNCT02826681Phase 2Results posted
- Can Iron Lessen Anemia Due to Cancer and Chemotherapy: A Study to Investigate the Efficacy and Safety of Injectafer®CompletedNCT02453334Phase 3Results posted
- A Study to Characterize the PK and PD Profile of IV FCM in Pediatric Subjects 1-17 Years Old With IDACompletedNCT02410213Phase 2Results posted
- Blinded Randomized Placebo-Controlled Study Efficacy and Safety of Injectafer in ID Patients With FibromyalgiaCompletedNCT02409459Phase 2Results posted
- Placebo-Controlled Study to Investigate the Efficacy & Safety of Injectafer in the Treatment of RLSCompletedNCT02397057Phase 3Results posted
- Treatment Response of Injectafer vs Oral Iron to Baseline Hepcidin Levels in Patients With Iron Deficiency Anemia (IDA) Secondary to Inflammatory Bowel Disease (IBD) or Gastric BypassCompletedNCT02086968Phase 4Results posted
- The Use of Iron Therapy for Patients With Anemia After Caesarean SectionTerminatedNCT01975272Phase 4Results posted
- Evaluate the Utility of Serum Hepcidin Levels to Predict Response to Oral or IV IronCompletedNCT01950247Phase 4Results posted
- Intravenous (IV) Iron Preparation (VIT-45) in the Treatment of Restless Legs Syndrome (RLS)CompletedNCT01382901Phase 2Results posted
- Hypophosphatemia With Ferric Carboxymaltose Vs. Iron Dextran in Iron Deficiency Secondary to Heavy Uterine BleedingCompletedNCT01307007Phase 2Results posted
- Intravenous Ferric Carboxymaltose vs IV Iron Sucrose or IV Iron Dextran in Treating Iron Deficiency Anemia in WomenCompletedNCT01290315Phase 2Results posted
- Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)CompletedNCT00994318Phase 3Results posted
- Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA)CompletedNCT00982007Phase 3Results posted
- Evaluation of Efficacy and Safety of Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia and Impaired Renal FunctionCompletedNCT00981045Phase 3Results posted
- Safety and Tolerability of Intravenous VIT-45 in Patients With Iron Deficiency AnemiaCompletedNCT00740246Phase 3Results posted
- Safety and Tolerability of a Single Dose of FCM vs. Standard of Care in Treating Iron Deficiency AnemiaCompletedNCT00704353Phase 3Results posted
- Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Iron Dextran in Treating Iron Deficiency AnemiaCompletedNCT00704028Phase 3Results posted
- Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Standard of Care in Treating Iron Deficiency AnemiaCompletedNCT00703937Phase 3Results posted
- Intravenous Iron Metabolism in Restless Legs SyndromeCompletedNCT00685815Phase 2Results posted
- Safety of FCM vs. Standard of Care in Treating Iron Deficiency Anemia in Heavy Uterine Bleeding and Post Partum PatientsCompletedNCT00548860Phase 3Results posted
- Safety and Tolerability of FCM vs Standard of Care in Treating Iron Deficiency Anemia in Chronic Kidney Disease PatientsCompletedNCT00548691Phase 3Results posted
- Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in Subjects Who Display Postpartum AnemiaCompletedNCT00396292Phase 3Results posted
- Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine BleedingCompletedNCT00395993Phase 3Results posted
- Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum PatientsCompletedNCT00354484Phase 3Results posted
- VIT45 Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney DiseaseCompletedNCT00317239Phase 3Results posted
- Long Term Safety Study of (VIT45) Extension Study: Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney DiseaseCompletedNCT00317226Phase 3Results posted
- Maternal Fatigue After Postpartum Anemia Treatment With Intravenous Ferric Carboxymaltose and Oral Iron TherapyCompletedNCT07880314Phase 4
- Comparative Analysis of Oral Iron With Injectable Ferric Carboxymaltose for Post Partum Iron Deficiency AnaemiaCompletedNCT07648628Phase 2/3
- EFFICACY OF IV VERSUS ORAL IRON IN THE TREATMENT OF IRON DEFICIENCY ANEMIA DURING PREGNANCYCompletedNCT07384663Phase 1
- Comparison of the Mean Change in Hemoglobin With Ferric Carboxymaltose and IV Iron Sucrose in Anemic Antenatal PatientsCompletedNCT07115121Not applicable
- IRONICA: IRON Repletion In Heart Failure - A Comparison of Oral and IV ApproachesTerminatedNCT07053475Phase 4
- Efficacy of Ferric Carboxymaltose Versus Iron Sucrose in Non-dialysis Dependent Chronic Kidney Disease PatientsCompletedNCT06994065Not applicable
- Ferric Carboxymaltose Versus Iron Sucrose for Treating Anemia in Pregnant WomenCompletedNCT06911034Phase 4
- Bioequivalence Study of Ferric Carboxymaltose Injection in Healthy Chinese ParticipantsCompletedNCT06895993Phase 1
- Hypoferritinemia Without Anemia Among Reproductive Age FemalesCompletedNCT06437080Not applicable
- Effect of Cordyceps Militaris Beverage on the Immune ResponseCompletedNCT06138444Not applicable
- The Effect of Preoperative Ferric Carboxymaltose Administration on Mortality in Geriatric Hip FracturesCompletedNCT06080893Phase 4
- Bioequivalence Study of Ferric Carboxymaltose Injection in Participants With Iron Deficiency AnaemiaCompletedNCT06080555Phase 1
- Prevention of Iron Deficiency Anemia Post-deliveryCompletedNCT05590260Phase 3
- Management of Preoperative Anaemia in Surgical OncologyStatus unknownNCT05505006Phase 4
- Iron Substitution With Ferric Carboxymaltose as Treatment Strategy for Heart Failure Patients With Preserved Ejection FractionWithdrawnNCT05477498Phase 4
- Intravenous Iron Supplement to Prevent Postoperative Delirium After Hip Fracture SurgeryStatus unknownNCT05429749Phase 4
- Reducing Anemia in Pregnancy in India: the RAPIDIRON TrialCompletedNCT05358509Phase 4
- Iron Infusion Into a Vein Compared to Iron Tablet Taken by Mouth for Treating Iron Deficiency Anemia in Pregnancy (IVON)CompletedNCT04976179Phase 3
- Safety, Tolerability, PK and PD of Intravenous Ferric Carboxymaltose in Infants With Iron Deficiency AnemiaWithdrawnNCT04968379Phase 2
- Iron and COVID-19 Vaccine ResponseCompletedNCT04915820Not applicable
- Iron and Vaccine ResponseCompletedNCT04912661Not applicable
- Effect of Intravenous Ferric Carboxymaltose on Hemoglobin Response and Transfusion in Patients With Iron Deficiency Anemia After Off-Pump Coronary Artery Bypass GraftingStatus unknownNCT04898569Phase 4
- The Iron and Muscle StudyCompletedNCT04862715Phase 4
- Do Iron And Vitamin B12 Injections Given Together, Improve Hemoglobin In Patients On Hemodialysis?Status unknownNCT04627181Phase 4
- Perioperative Management in Gynaecological Carcinoma SurgeryWithdrawnNCT04625530Phase 3
- Iron Deficiency as an Ignored Cause of InfertilityStatus unknownNCT04510870Phase 4
- Treatment of Anemia With Intravenous Iron in Patients Listed for Orthotopic Liver TransplantationStatus unknownNCT04475887Phase 4
- Intravenous Iron Injection in Cancer Patients With AnemiaStatus unknownNCT04187716Phase 3
- Intraoperative IV Iron on Postoperative Red Blood Cell RecoveryStatus unknownNCT04035902Phase 4
- Iron in Patients With Cardiovascular DiseaseTerminatedNCT03991000Phase 3
- Intravenous Iron Carboxymaltose, Isomaltoside and Oral Iron Sulphate for Postpartum AnemiaCompletedNCT03957057Phase 3
- Ferric Carboximaltose on Intra-myocardial Iron Load in Patients With Heart FailureStatus unknownNCT03871699Phase 4
- Effects of Iron Therapy in Heart Failure With Preserved Ejection Fraction and Iron Deficiency (PREFER-HF)CompletedNCT03833336Phase 3
- Effect of Ferric Carboxymaltose on Exercise Capacity After Kidney TransplantationCompletedNCT03769441Phase 3
- Effects of Ferinject® on Anemia and Transfusion Rates After Cardiac SurgeryCompletedNCT03759964Phase 4
- Iron Status and Cardiopulmonary PhysiologyCompletedNCT03707249Not applicable
- Postoperative Replacement of Intraoperative Iron LossesCompletedNCT03680456Phase 4
- Intravenous Iron in Adults With Cystic FibrosisCompletedNCT03632525Phase 4
- Impact and Evaluation of the Management of Iron Deficiency With or Without Anemia in Patients With CancerCompletedNCT03625661Not applicable
- Preoperative Intravenous Ferric Carboxymaltose and Placebo in the Treatment of Patients Undergoing Cardiac SurgeryStatus unknownNCT03574311Phase 4
- Effect of Preoperative Ferric Carboxymaltose After Simultaneous Bilateral Total Knee ArthroplastyStatus unknownNCT03561506Phase 4